Janis Miyasaki

Citado por

	Total	Desde 2019
Citas	27473	11848
Índice h	63	48
Índice i10	122	108

2300

1150

575

1725

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202472 72 75 72 137 178 208 270 395 580 678 817 1005 1201 1179 1202 1257 1287 1363 1439 1516 1658 1894 2004 2224 2025 2023

Acceso público

Ver todo

56 artículos

18 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Anthony E LangUniversity of TorontoDirección de correo verificada de uhnres.utoronto.ca
Susan FoxAssociate Professor University of TorontoDirección de correo verificada de uhnresearch.ca
Valerie VoonUniversity of CambridgeDirección de correo verificada de cam.ac.uk
am lozanoUniversity of TorontoDirección de correo verificada de uhnresearch.ca
Werner PoeweProfessor NeurologieDirección de correo verificada de i-med.ac.at
Olivier RASCOLUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)Dirección de correo verificada de univ-tlse3.fr
Glenn T StebbinsProfessor Emeritus of Neurological Sciences, Rush University Medical CenterDirección de correo verificada de rush.edu
Elena MoroGrenoble Alpes UniversityDirección de correo verificada de chu-grenoble.fr
Jonathan Dostrovskyuniversity of torontoDirección de correo verificada de utoronto.ca
Rajesh PahwaProfessor of Neurology, University of Kansas Medical Center Dirección de correo verificada de kumc.edu
Pablo Martinez-MartinMadrid, SpainDirección de correo verificada de ciberned.es
Anette SchragUniversity College LondonDirección de correo verificada de doctors.org.uk
Warren OlanowMount Sinai School of MedicineDirección de correo verificada de clintrex.com
Stanley FahnColumbia UniversityDirección de correo verificada de columbia.edu
Un Jung KangNew York UniversityDirección de correo verificada de nyu.edu
Jacobus J van HiltenHoogleraar Neurologie, Leiden University Medical CenterDirección de correo verificada de lumc.nl
Helen Bronte-Stewartjohn e cahill family professor of neurology and neurological sciences, stanford universityDirección de correo verificada de stanford.edu
Steven PantilatProfessor of Medicine, University of California, San FranciscoDirección de correo verificada de ucsf.edu
Wayne MartinUniversity of AlbertaDirección de correo verificada de ualberta.ca
Bénédicte BallangerTenured Researcher, Centre de Recherche en Neurosciences de Lyon, Inserm U1028 - CNRS UMR5292Dirección de correo verificada de cnrs.fr

Seguir

Janis Miyasaki

University of Alberta

Dirección de correo verificada de ualberta.ca

Movement Disorders Neurodegenerative disease palliative care clinical trials evidence-based medicine


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008	6880	2008
Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004	2350	2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial Parkinson Study Group, Parkinson Study Group Jama 284 (15), 1931-1938, 2000	1099	2000
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review):[RETIRED] Report of the Quality Standards Subcommittee of … R Pahwa, SA Factor, KE Lyons, WG Ondo, G Gronseth, H Bronte-Stewart, ... Neurology 66 (7), 983-995, 2006	750	2006
Effect of GPi pallidotomy on motor function in Parkinson's disease AM Lozano, AE Lang, N Galvez-Jimenez, J Miyasaki, J Duff, ... The Lancet 346 (8987), 1383-1387, 1995	727	1995
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ... Archives of neurology 61 (7), 1044-1053, 2004	700	2004
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of Neurology 59 (12), 1937-1943, 2002	700	2002
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards … JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ... Neurology 66 (7), 996-1002, 2006	697	2006
Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review JM Miyasaki, W Martin, O Suchowersky, WJ Weiner, AE Lang Neurology 58 (1), 11-17, 2002	591	2002
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease D Weintraub, S Hoops, JA Shea, KE Lyons, R Pahwa, ... Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009	580	2009
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [¹¹C] raclopride PET study TDL Steeves, J Miyasaki, M Zurowski, AE Lang, G Pellecchia, ... Brain 132 (5), 1376-1385, 2009	553	2009
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee … DM Simpson, A Blitzer, A Brashear, C Comella, R Dubinsky, M Hallett, ... Neurology 70 (19), 1699-1706, 2008	548	2008
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease C Zadikoff, SH Fox, DF Tang‐Wai, T Thomsen, RMA De Bie, P Wadia, ... Movement disorders 23 (2), 297-299, 2008	529	2008
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease V Voon, K Hassan, M Zurowski, M De Souza, T Thomsen, S Fox, AE Lang, ... Neurology 67 (7), 1254-1257, 2006	528	2006
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review):[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee of the … DM Simpson, JM Gracies, HK Graham, JM Miyasaki, M Naumann, ... Neurology 70 (19), 1691-1698, 2008	497	2008
Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease V Voon, T Thomsen, JM Miyasaki, M de Souza, A Shafro, SH Fox, ... Archives of Neurology 64 (2), 212-216, 2007	413	2007
Prospective prevalence of pathologic gambling and medication association in Parkinson disease V Voon, K Hassan, M Zurowski, S Duff-Canning, M De Souza, S Fox, ... Neurology 66 (11), 1750-1752, 2006	409	2006
Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of Neurology TA Zesiewicz, KL Sullivan, I Arnulf, KR Chaudhuri, JC Morgan, ... Neurology 74 (11), 924-931, 2010	380	2010
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice A Keller, A Westenberger, MJ Sobrido, M Garcia-Murias, A Domingo, ... Nature genetics 45 (9), 1077-1082, 2013	327	2013
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis [RETIRED] Report of the Therapeutics and Technology Assessment … JJ Marriott, JM Miyasaki, G Gronseth, PW O'Connor Neurology 74 (18), 1463-1470, 2010	306	2010

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores